BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  C2C Services & Suppliers™
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Syrrx, Inc. 

10410 Science Center Drive

San Diego  California  92121  U.S.A.
Phone: 858-622-8528 Fax: 858-550-0526


SEARCH JOBS




Industry
Biotechnology






 Company News
Takeda Pharmaceutical Co. Ltd. (TKDG.DE) To Acquire Syrrx, Inc.10/19/2005 5:12:38 PM
Syrrx, Inc. Researchers Report Atomic Structure Of Human HSD-1, An Important Target For The Potential Treatment Of Diabetes10/19/2005 5:12:05 PM
Syrrx, Inc. Researchers Report Atomic Structure Of c-KIT In Complex With Gleevec10/19/2005 5:11:54 PM
PPD, Inc. (PPDI) And Syrrx, Inc. File Investigational New Drug Application For DPP IV Inhibitor To Treat Type II Diabetes10/19/2005 5:11:50 PM
Syrrx, Inc. Announces Research Collaboration With Biogen Idec, Inc. (Massachusetts) (BIIB) And Receives First Success Payment10/19/2005 5:11:32 PM
Roche (RHHBY) And Syrrx, Inc. Initiate Strategic Alliance In Diabetes And Cancer10/19/2005 5:11:16 PM
Syrrx, Inc. Awarded ATP Grant To Pursue High-Throughput Crystallization Of Membrane Proteins Using Heterogenous Nucleants10/19/2005 5:11:11 PM
Syrrx, Inc. Receives Second And Third Success Payments And Announces Completion Of Research Agreement With Biogen Idec, Inc. (Massachusetts) (BIIB)10/19/2005 5:11:01 PM
PPD, Inc. (PPDI) And Syrrx, Inc. Collaborate To Develop Orally-Delivered DP4 Inhibitors To Treat Diabetes And Other Major Diseases10/19/2005 5:10:49 PM
Fluidigm Corporation Granted Non-Exclusive Sublicense To Syrrx, Inc.'s Nanovolume Crystallization(R) Patents10/19/2005 5:09:55 PM
12